Suchergebnisse - "Sarilumab"

PubPharm (14)

1

Anti-Interleukin-6 Antibodies for Autoimmune Retinopathy with Macular Edema

enthalten in: Ophthalmology. Retina | 2022

von Deaner, J. | Jaffe, G. | Keenan, R. | +2

2

IL-6 inhibition in the treatment of COVID-19 : A meta-analysis and meta-regression

enthalten in: The Journal of infection | 2021

von Tharmarajah, E. | Buazon, A. | Patel, V. | +11

CommentIn: J Infect. 2021 Jul;83(1):e11-e13. - PMID 34029628

3

Interleukin-6 receptor blockade or TNFα inhibition for reducing glycaemia in patients with RA and diabetes : post hoc analyses of three randomised, controlled trials

enthalten in: Arthritis research & therapy | 2020

von Genovese, M. | Burmester, G. | Hagino, O. | +6

4

Interleukin-6 receptor blockade or TNFα inhibition for reducing glycaemia in patients with RA and diabetes: post hoc analyses of three randomised, controlled trials

enthalten in: Arthritis Research & Therapy | 2020

von Genovese, M. | Burmester, G. | Hagino, O. | +6

5

Interleukin-6 receptor blockade or TNFα inhibition for reducing glycaemia in patients with RA and diabetes: post hoc analyses of three randomised, controlled trials

enthalten in: Arthritis Research & Therapy | 2020

von Genovese, M. | Burmester, G. | Hagino, O. | +6

6

Interleukin-6 receptor blockade or TNFα inhibition for reducing glycaemia in patients with RA and diabetes: post hoc analyses of three randomised, controlled trials

in: Arthritis Research & Therapy | 2020

von Mark C. Genovese | Gerd R. Burmester | Owen Hagino | +6

7

Il-6 Involvement in pain, fatigue and mood disorders in rheumatoid arthritis and the effects of Il-6 inhibitor sarilumab

enthalten in: Pharmacological research | 2019

von Atzeni, F. | Nucera, V. | Masala, I. | +2

8

Economic Evaluation of Sarilumab in the Treatment of Adult Patients with Moderately-to-Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic Disease-Modifying Antirheumatic Drugs

enthalten in: Advances in therapy | 2019

von Muszbek, N. | Proudfoot, C. | Fournier, M. | +5

9

Economic Evaluation of Sarilumab in the Treatment of Adult Patients with Moderately-to-Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic Disease-Modifying Antirheumatic Drugs

enthalten in: Advances in therapy | 2019

von Muszbek, N. | Proudfoot, C. | Fournier, M. | +5

10

Economic Evaluation of Sarilumab in the Treatment of Adult Patients with Moderately-to-Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic Disease-Modifying Antirheumatic Drugs

enthalten in: Advances in therapy | 2019

von Muszbek, N. | Proudfoot, C. | Fournier, M. | +5